IL17A and Miyoshi myopathy: Ming Chen et al. reported that the frequency of CD4 + PD-1+, CD8 + PD-1+/LAG-3+, as well as IL-6, IL-17, and TNF-α were found as risk factors for the incidence of relapsed/refractory MM (RRMM) in all MM [38].